Evidence Level
Strong
2 Clinical Trials
4 Documented Benefits
4/5 Evidence Score

Nitrosigine® (Nutrition 21) is a patented, inositol-stabilized arginine silicate complex specifically engineered to overcome the poor bioavailability of standard L-arginine. With over 30 studies supporting its efficacy, Nitrosigine significantly elevates and sustains plasma arginine and nitric oxide levels for up to 6 hours — making it one of the most researched and effective pump and performance ingredients in the pre-workout market.

Studied Dose 1,500 mg/day; most studies use 1,500 mg taken 30–60 minutes pre-exercise
Active Compound Inositol-stabilized arginine silicate — Nitrosigine® by Nutrition 21 (patented complex)

Benefits

Superior nitric oxide and arginine elevation

Nitrosigine produces significantly greater and longer-lasting increases in plasma arginine and nitric oxide vs. standard L-arginine. The inositol-silicate complex stabilizes arginine, increases intestinal absorption, and extends the duration of NO elevation to 6 hours — vs. L-arginine's 1–2 hour window.

Blood flow and muscle pump

Elevated nitric oxide dilates blood vessels via the arginine-eNOS-NO pathway, increasing muscle blood flow, nutrient delivery, and the pump sensation during resistance training. Clinical studies confirm significantly greater brachial artery flow-mediated dilation vs. L-arginine and placebo.

Cognitive performance and focus

A 2020 clinical study found a single dose of Nitrosigine significantly improved cognitive flexibility and executive function in active young men vs. placebo — effects attributed to increased cerebral blood flow via nitric oxide-mediated vasodilation. Benefits were measurable within 15 minutes of ingestion.

Recovery and muscle damage reduction

Nitrosigine reduces creatine kinase and other muscle damage biomarkers post-exercise, suggesting a protective effect on muscle tissue during intense training. Faster recovery between sessions supports greater training frequency and progressive overload.

Mechanism of action

1

eNOS-mediated nitric oxide production

Arginine (released from the Nitrosigine complex) is the exclusive substrate for endothelial nitric oxide synthase (eNOS), which converts arginine to citrulline and NO in vascular endothelial cells. NO activates soluble guanylate cyclase, increasing cGMP and triggering vascular smooth muscle relaxation and vasodilation.

2

Silicon bioavailability contribution

The silicate component of Nitrosigine contributes orthobiological silicon to the complex — a mineral that supports vascular endothelial integrity, collagen synthesis in vessel walls, and endothelial function. Silicon may contribute to endothelial health effects beyond the direct arginine-NO pathway.

3

Inositol-mediated cellular signaling

Inositol in the Nitrosigine complex contributes phosphatidylinositol signaling pathway activity, which plays a role in insulin signaling, cellular membrane function, and potentially in the enhanced arginine absorption and retention observed vs. standard L-arginine.

Clinical trials

1
Nitrosigine® vs L-Arginine vs L-Citrulline for Plasma Arginine — Clinical Trial

Clinical trial comparing Nitrosigine® (1,500 mg = 222 mg elemental arginine), L-arginine HCl (1,500 mg), L-citrulline (1,500 mg), and placebo on plasma arginine, salivary nitric oxide, blood flow. (— or related Nitrosigine trials)

Healthy adults. Acute PK study.

Nitrosigine produced higher and longer-lasting plasma arginine elevations than equivalent doses of L-arginine HCl. L-citrulline also produced higher arginine than oral L-arginine. Critical caveat: industry-funded (Nutrition 21); Nitrosigine contains much less elemental arginine (222 mg) than L-arginine HCl (1,200 mg elemental in 1,500 mg dose) yet claims comparable/superior effects — the claim relies on improved bioavailability of bound arginine.

2
Nitrosigine® for Cognitive Performance — Clinical Trial

Clinical trial of Nitrosigine® (1,500 mg) vs placebo measuring cognitive flexibility and executive function in active young men. (— or related)

Active young men.

Acute Nitrosigine® improved cognitive flexibility scores within 15 minutes vs placebo. Industry-funded. Effect sizes modest; replication outside manufacturer-funded research limited.

Side effects and drug interactions

Common Potential side effects

Very well tolerated across all published human studies
No significant adverse effects reported at 1,500 mg/day clinical dose
Mild GI discomfort possible in sensitive individuals — take with food

Important Drug interactions

Erectile dysfunction medications (sildenafil, tadalafil) — both increase cGMP/NO; additive vasodilation risk; avoid combining
Antihypertensive medications — additive blood pressure-lowering effects; monitor
Anticoagulants — arginine may mildly affect platelet function; monitor with warfarin

Frequently asked questions about Nitrosigine® (Arginine Silicate)

What is Nitrosigine?

Nitrosigine® (Nutrition 21) is a patented, inositol-stabilized arginine silicate complex specifically engineered to overcome the poor bioavailability of standard L-arginine.

What is Nitrosigine used for?

Nitrosigine is researched primarily for Athletic Performance, Cardiovascular, and Cognitive. Nitrosigine produces significantly greater and longer-lasting increases in plasma arginine and nitric oxide vs. standard L-arginine.

What is the recommended dosage of Nitrosigine?

The clinically studied dose is 1,500 mg/day; most studies use 1,500 mg taken 30–60 minutes pre-exercise Always follow the product label and check with a healthcare provider for personal advice.

Is Nitrosigine safe, and does it have side effects?

For most healthy adults, Nitrosigine is well tolerated at studied doses. Reported effects can include: Very well tolerated across all published human studies No significant adverse effects reported at 1,500 mg/day clinical dose It may also interact with some medications. Nitrosigine is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Nitrosigine interact with any medications?

Possible interactions include: Erectile dysfunction medications (sildenafil, tadalafil) — both increase cGMP/NO; additive vasodilation risk; avoid combining Antihypertensive medications — additive blood pressure-lowering effects; monitor If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Nitrosigine?

NutraSmarts rates the evidence for Nitrosigine as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Kalman DS, Feldman S, Samson A, Krieger DR A clinical evaluation to determine the safety, pharmacokinetics, and pharmacodynamics of an inositol-stabilized arginine silicate dietary supplement in healthy adult males. Clinical Pharmacology: Advances and Applications. 2015;7:103-9. doi: 10.2147/CPAA.S84206.PubMedUsed to support: Pharmacokinetic/pharmacodynamic study of Nitrosigine (inositol-stabilized arginine silicate) showing it raises plasma arginine and serum silicon and increases salivary nitric oxide/nitrite. Supports the arginine/NO-biomarker claim; very small (n=10), short, single-arm and manufacturer (Nutrition21)-funded.
  2. Kalman D, Harvey PD, Perez Ojalvo S, Komorowski J Randomized Prospective Double-Blind Studies to Evaluate the Cognitive Effects of Inositol-Stabilized Arginine Silicate in Healthy Physically Active Adults. Nutrients. 2016;8(11):736. doi: 10.3390/nu8110736.PubMedUsed to support: Double-blind trials reporting short-term cognitive benefits (reduced reaction time, better performance on demanding tasks) after acute Nitrosigine. Backs the cognition claim, but the evidence is preliminary and manufacturer (Nutrition21)-funded.
  3. Gills JL, Campitelli A, Jones MD, Paulson S, Myers JR, Madero EN, et al. Acute Inositol-Stabilized Arginine Silicate Improves Cognitive Outcomes in Healthy Adults. Nutrients. 2021;13(12):4272. doi: 10.3390/nu13124272.PubMedUsed to support: Acute double-blind crossover trial reporting improved cognitive-test outcomes after a single Nitrosigine dose. Adds a more recent (partly academic) corroboration of acute cognitive effects, though it remains a small, short-duration study with industry funding/co-authorship.
  4. Rogers JM, Gills J, Gray M Acute effects of Nitrosigine and citrulline malate on vasodilation in young adults. Journal of the International Society of Sports Nutrition. 2020;17(1):12. doi: 10.1186/s12970-020-00343-y.PubMedUsed to support: Crossover trial showing acute Nitrosigine (1.5 g) significantly increased flow-mediated (endothelium-dependent) vasodilation, comparable to 8 g citrulline malate. Supports the blood-flow/'pump' claim with an objective vascular measure; small sample and acute design limit conclusions about chronic ergogenic benefit.